Immunostics guilty of fraudulent export notes
This article was originally published in Clinica
Executive Summary
Immunostics, a US manufacturer of microbiological, serological and immunological reagents, has pleaded guilty in the US District Court of Newark, New Jersey, to providing fraudulent export documents to the US Department of Commerce and the US Customs Service. Sentencing has not yet occurred but the parties have entered into a plea agreement in which the Ocean, New Jersey-based company would be fined $48,000.